Tumor-specific expression of vascular endothelial growth factor receptor 2 but not vascular endothelial growth factor or human epidermal growth factor receptor 2 is associated with impaired response to adjuvant tamoxifen in premenopausal breast cancer.
Rydén, Lisa LU
; Jirström, Karin
LU
; Bendahl, Pär-Ola
LU
; Fernö, Mårten
LU
; Nordenskjöld, Bo
; Stål, Olle
; Thorstenson, Sten
; Jönsson, Per-Ebbe
LU
and Landberg, Göran
LU
(2005)
In Journal of Clinical Oncology
23(21).
p.4695-4704
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/142006
- author
- Rydén, Lisa
LU
; Jirström, Karin
LU
; Bendahl, Pär-Ola
LU
; Fernö, Mårten
LU
; Nordenskjöld, Bo
; Stål, Olle
; Thorstenson, Sten
; Jönsson, Per-Ebbe
LU
and Landberg, Göran
LU
- organization
- publishing date
- 2005
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Journal of Clinical Oncology
- volume
- 23
- issue
- 21
- pages
- 4695 - 4704
- publisher
- American Society of Clinical Oncology
- external identifiers
-
- pmid:16034044
- wos:000230872000020
- scopus:23044463773
- ISSN
- 1527-7755
- DOI
- 10.1200/JCO.2005.08.126
- language
- English
- LU publication?
- yes
- id
- 0e0cedc2-99ef-4151-95d3-4bf8bcc66f06 (old id 142006)
- alternative location
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16034044&dopt=Abstract
- date added to LUP
- 2016-04-01 11:57:57
- date last changed
- 2024-01-08 03:07:03
@article{0e0cedc2-99ef-4151-95d3-4bf8bcc66f06,
author = {{Rydén, Lisa and Jirström, Karin and Bendahl, Pär-Ola and Fernö, Mårten and Nordenskjöld, Bo and Stål, Olle and Thorstenson, Sten and Jönsson, Per-Ebbe and Landberg, Göran}},
issn = {{1527-7755}},
language = {{eng}},
number = {{21}},
pages = {{4695--4704}},
publisher = {{American Society of Clinical Oncology}},
series = {{Journal of Clinical Oncology}},
title = {{Tumor-specific expression of vascular endothelial growth factor receptor 2 but not vascular endothelial growth factor or human epidermal growth factor receptor 2 is associated with impaired response to adjuvant tamoxifen in premenopausal breast cancer.}},
url = {{http://dx.doi.org/10.1200/JCO.2005.08.126}},
doi = {{10.1200/JCO.2005.08.126}},
volume = {{23}},
year = {{2005}},
}